search
Back to results

Treatment for Lifting Upper Arm Lax Skin

Primary Purpose

Lax Skin

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sofwave
Sponsored by
Sofwave Medical LTD
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Lax Skin focused on measuring upper arms, lax skin

Eligibility Criteria

35 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Male or female subjects > 35 years of age and < 70 years of age.
  2. Not pregnant or lactating and must be either post-menopausal, surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment (i.e., oral contraceptives, contraceptive implant, barrier methods with spermicide) or abstinence.
  3. Desire to undergo upper arms skin lax lifting treatments.
  4. Subject has clearly visible lax skin on the upper arm, which in the investigator's opinion, may benefit from the treatment.
  5. Subject agrees to maintain his/her weight (i.e., within 5% of total body weight) by not making any major changes in their diet or exercise routine during the course of the study.
  6. Able and willing to comply with all visits, treatments and evaluations schedules and requirements.
  7. Willing to have research photos taken of treatment areas.
  8. Subject agrees not to undergo any other upper arm skin lax treatments for a period of 3 months following Sofwave treatment.
  9. Able to understand and provide written Informed Consent.

Exclusion Criteria:

  1. Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding.
  2. Skin disorders (skin infections or rashes, extensive scarring, psoriasis, etc.) in the treatment area.
  3. Medical disorder that would hinder the wound healing or immune response (such as blood disorder, inflammatory disease, etc.).
  4. History of Epileptic seizures.
  5. Known allergy to lidocaine or epinephrine or antibiotics.
  6. Active malignancy or history of malignancy in the past 5 years.
  7. Suffering from significant concurrent illness, such as cardiac disorders, diabetes (type I or II), lupus, porphyria, or pertinent neurological disorders (i.e. any disease state that in the opinion of the investigator may interfere with the anesthesia, treatment, or healing process).
  8. History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or currently using immunosuppressive medications.
  9. Suffering from hormonal imbalance, whether related to thyroid, pituitary, or androgen.
  10. History of significant lymphatic drainage problems.
  11. Currently heavy smoker or has history of heavy smoking (25 cigarettes per day or more) in past 10 years.
  12. History of chronic drug or alcohol abuse.
  13. History of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising.
  14. Currently taking or has taken diet pills or weight control supplements within the past month.
  15. BMI>=30kg/m2
  16. Non-stable weight nominally ±5% for at the past month.
  17. Active implanted device such as a pacemaker, defibrillator, or drug delivery system.
  18. History of epidermal or dermal disorders (particularly involving collagen or microvascularity), including collagen vascular disease or vasculitic disorders.
  19. History of a fat reduction procedure (e.g., liposuction, surgery, lipolytic agents, etc.).
  20. History of prior surgery in the upper arms.
  21. Excessive subcutaneous fat on the upper arms.
  22. Severe solar elastosis on the intended to treat area.
  23. Significant scarring, atrophic scars in the area to be treated, or has a history of atrophic scars or keloids or prone to bruising.
  24. Tattoo or former tattoo at or near treatment area.
  25. Presence of an implant in or adjacent to area of intended treatment (upper arms).
  26. History of ablative or non-ablative resurfacing/rejuvenation laser treatment or light treatment within the past 6 months, dermabrasion or deep peeling within the past 12 months on the intended to treat area.
  27. Inability to understand the protocol or to give informed consent.
  28. On-going use of psychiatric medication.
  29. Unable or unwilling to comply with the study requirements and procedures.
  30. Currently enrolled in a clinical study of any other unapproved investigational drug or device.
  31. Any other condition that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.

Sites / Locations

  • Laser & Skin Surgery Center of Northern California
  • Advanced Dermatology
  • United Skin Specialists
  • Laser & Skin Surgery Center of New York®

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Upper Arm

Arm Description

Outcomes

Primary Outcome Measures

Rate of improvement of upper arms lax skin
following Sofwave treatment as evaluated by independent masked reviewers

Secondary Outcome Measures

Full Information

First Posted
April 19, 2022
Last Updated
November 20, 2022
Sponsor
Sofwave Medical LTD
search

1. Study Identification

Unique Protocol Identification Number
NCT05358327
Brief Title
Treatment for Lifting Upper Arm Lax Skin
Official Title
Safety and Efficacy of Sofwave Treatment to Lift Upper Arm Lax Skin
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 1, 2022 (Actual)
Primary Completion Date
May 2023 (Anticipated)
Study Completion Date
June 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Sofwave Medical LTD

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.
Detailed Description
Eligible patients will receive 2 treatments on both upper arms (4-6 weeks apart) using the Sofwave System. Treatment may be administered after the enrollment and screening at the first visit, or it may occur later following the enrollment and screening activities based on site scheduling availabilities. All patients will return to the clinic for follow up visit at 3 months ± 2 weeks post last treatment (FU1). Methodology described in the protocol to evaluate efficacy and safety of treatments will be carried out at each visit at the clinic.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lax Skin
Keywords
upper arms, lax skin

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Upper Arm
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Sofwave
Other Intervention Name(s)
SUPERB
Intervention Description
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.
Primary Outcome Measure Information:
Title
Rate of improvement of upper arms lax skin
Description
following Sofwave treatment as evaluated by independent masked reviewers
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male or female subjects > 35 years of age and < 70 years of age. Not pregnant or lactating and must be either post-menopausal, surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment (i.e., oral contraceptives, contraceptive implant, barrier methods with spermicide) or abstinence. Desire to undergo upper arms skin lax lifting treatments. Subject has clearly visible lax skin on the upper arm, which in the investigator's opinion, may benefit from the treatment. Subject agrees to maintain his/her weight (i.e., within 5% of total body weight) by not making any major changes in their diet or exercise routine during the course of the study. Able and willing to comply with all visits, treatments and evaluations schedules and requirements. Willing to have research photos taken of treatment areas. Subject agrees not to undergo any other upper arm skin lax treatments for a period of 3 months following Sofwave treatment. Able to understand and provide written Informed Consent. Exclusion Criteria: Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding. Skin disorders (skin infections or rashes, extensive scarring, psoriasis, etc.) in the treatment area. Medical disorder that would hinder the wound healing or immune response (such as blood disorder, inflammatory disease, etc.). History of Epileptic seizures. Known allergy to lidocaine or epinephrine or antibiotics. Active malignancy or history of malignancy in the past 5 years. Suffering from significant concurrent illness, such as cardiac disorders, diabetes (type I or II), lupus, porphyria, or pertinent neurological disorders (i.e. any disease state that in the opinion of the investigator may interfere with the anesthesia, treatment, or healing process). History of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or currently using immunosuppressive medications. Suffering from hormonal imbalance, whether related to thyroid, pituitary, or androgen. History of significant lymphatic drainage problems. Currently heavy smoker or has history of heavy smoking (25 cigarettes per day or more) in past 10 years. History of chronic drug or alcohol abuse. History of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising. Currently taking or has taken diet pills or weight control supplements within the past month. BMI>=30kg/m2 Non-stable weight nominally ±5% for at the past month. Active implanted device such as a pacemaker, defibrillator, or drug delivery system. History of epidermal or dermal disorders (particularly involving collagen or microvascularity), including collagen vascular disease or vasculitic disorders. History of a fat reduction procedure (e.g., liposuction, surgery, lipolytic agents, etc.). History of prior surgery in the upper arms. Excessive subcutaneous fat on the upper arms. Severe solar elastosis on the intended to treat area. Significant scarring, atrophic scars in the area to be treated, or has a history of atrophic scars or keloids or prone to bruising. Tattoo or former tattoo at or near treatment area. Presence of an implant in or adjacent to area of intended treatment (upper arms). History of ablative or non-ablative resurfacing/rejuvenation laser treatment or light treatment within the past 6 months, dermabrasion or deep peeling within the past 12 months on the intended to treat area. Inability to understand the protocol or to give informed consent. On-going use of psychiatric medication. Unable or unwilling to comply with the study requirements and procedures. Currently enrolled in a clinical study of any other unapproved investigational drug or device. Any other condition that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruthie Amir, MD
Organizational Affiliation
CMO
Official's Role
Study Director
Facility Information:
Facility Name
Laser & Skin Surgery Center of Northern California
City
Sacramento
State/Province
California
ZIP/Postal Code
95816
Country
United States
Facility Name
Advanced Dermatology
City
Lincolnshire
State/Province
Illinois
ZIP/Postal Code
60069
Country
United States
Facility Name
United Skin Specialists
City
Edina
State/Province
Minnesota
ZIP/Postal Code
55424
Country
United States
Facility Name
Laser & Skin Surgery Center of New York®
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Treatment for Lifting Upper Arm Lax Skin

We'll reach out to this number within 24 hrs